Exploring the advancements of Australian OPAT.

Tony LaiHorst ThieleBenjamin A RogersNadine HillockSuman AdhikariAlexander McNamaraMatthew D M Rawlins

Published in: Therapeutic advances in infectious disease (2023)

Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes. This is a comprehensive review of the current state of art Australian OPAT with vignettes of the types of OPAT models of care, antimicrobial prescribing and antimicrobial use. In addition, we highlight the similarities and differences between OPAT to other countries and describe Australian OPAT experiences with COVID-19 and paediatrics. Australian OPAT continues to advance with OPAT antifungals, novel treatment options and upcoming high-impact research.

Keyphrases

staphylococcus aureus
healthcare
primary care
coronavirus disease
sars cov
quality improvement
chronic pain
drug induced